Search for other papers by A Rouland in
Google Scholar
PubMed
INSERM Unit, LNC-UMR 1231, University of Burgundy, Dijon, France
Search for other papers by J-C Chauvet-Gelinier in
Google Scholar
PubMed
INSERM Unit, LNC-UMR 1231, University of Burgundy, Dijon, France
Search for other papers by A-L Sberna in
Google Scholar
PubMed
Search for other papers by E Crevisy in
Google Scholar
PubMed
Search for other papers by P Buffier in
Google Scholar
PubMed
Search for other papers by T Mouillot in
Google Scholar
PubMed
INSERM Unit, LNC-UMR 1231, University of Burgundy, Dijon, France
Search for other papers by J-M Petit in
Google Scholar
PubMed
INSERM Unit, LNC-UMR 1231, University of Burgundy, Dijon, France
Search for other papers by B Vergès in
Google Scholar
PubMed
Introduction Type 1 (T1D) and type 2 diabetes (T2D) are chronic diseases in which psychological determinants are an important field of research, not only to improve personalized treatment and educational strategies, but also to directly
MRC Epidemiology Unit, Department of Epidemiology and Department of Internal Medicine, University of Cambridge School of Clinical Medicine, Institute of Metabolic Science, Cambridge Biomedical Campus, Addenbrooke's Hospital, Post Box 285, Cambridge CB2 0QQ, UK
Search for other papers by Ali Abbasi in
Google Scholar
PubMed
Introduction Over the past decade, interest in studying biological markers (biomarkers) for type 2 diabetes (T2D) has increased intensely. This happened because multiple pathobiological processes may contribute to the disease progression, which
Search for other papers by Ram P Narayanan in
Google Scholar
PubMed
Search for other papers by Bo Fu in
Google Scholar
PubMed
Search for other papers by Adrian H Heald in
Google Scholar
PubMed
Search for other papers by Kirk W Siddals in
Google Scholar
PubMed
Search for other papers by Robert L Oliver in
Google Scholar
PubMed
Search for other papers by Julie E Hudson in
Google Scholar
PubMed
Search for other papers by Antony Payton in
Google Scholar
PubMed
Search for other papers by Simon G Anderson in
Google Scholar
PubMed
Search for other papers by Anne White in
Google Scholar
PubMed
Vascular Research Group, School of Community Based Medicine, Centre for Integrated Genomic Medical Research, Cardiovascular Research Group, Endocrinology and Diabetes, Salford R&D, Department of Endocrinology and Diabetes, Faculty of Medical, Human and Life Sciences, The University of Manchester, Manchester M13 9PT, UK
Search for other papers by William E R Ollier in
Google Scholar
PubMed
Vascular Research Group, School of Community Based Medicine, Centre for Integrated Genomic Medical Research, Cardiovascular Research Group, Endocrinology and Diabetes, Salford R&D, Department of Endocrinology and Diabetes, Faculty of Medical, Human and Life Sciences, The University of Manchester, Manchester M13 9PT, UK
Search for other papers by J Martin Gibson in
Google Scholar
PubMed
the renal glomerulus (3) . In this study, we used ‘real-world’ data to examine the hypothesis that concentrations of IGF2 and IGFBP2 at baseline were associated with longitudinal trends in glomerular filtration rate (GFR) in type 2 diabetes. Subjects
Search for other papers by Qiu-ming Yao in
Google Scholar
PubMed
Search for other papers by Bin Wang in
Google Scholar
PubMed
Search for other papers by Xiao-fei An in
Google Scholar
PubMed
Search for other papers by Jin-an Zhang in
Google Scholar
PubMed
Search for other papers by Liumei Ding in
Google Scholar
PubMed
Introduction Diabetes is a public health issue, and there are over 0.4 billion people suffering from diabetes over the world, and its prevalence is still increasing remarkably every year ( 1 ). Type 2 diabetes mellitus (T2DM) is the major type
Graduate School, Wannan Medical College, Wuhu, Anhui, People’s Republic of China
Search for other papers by Xi Zhang in
Google Scholar
PubMed
Graduate School, Wannan Medical College, Wuhu, Anhui, People’s Republic of China
Search for other papers by Xiurong Shen in
Google Scholar
PubMed
Institute of Endocrine and Metabolic Diseases, University of Science and Technology of China, Hefei, Anhui, People’s Republic of China
Search for other papers by Wan Zhou in
Google Scholar
PubMed
Institute of Endocrine and Metabolic Diseases, University of Science and Technology of China, Hefei, Anhui, People’s Republic of China
Search for other papers by Mengyun Xu in
Google Scholar
PubMed
Institute of Endocrine and Metabolic Diseases, University of Science and Technology of China, Hefei, Anhui, People’s Republic of China
Search for other papers by Yan Xing in
Google Scholar
PubMed
Institute of Endocrine and Metabolic Diseases, University of Science and Technology of China, Hefei, Anhui, People’s Republic of China
Search for other papers by Jianping Weng in
Google Scholar
PubMed
Institute of Endocrine and Metabolic Diseases, University of Science and Technology of China, Hefei, Anhui, People’s Republic of China
Search for other papers by Shandong Ye in
Google Scholar
PubMed
Institute of Endocrine and Metabolic Diseases, University of Science and Technology of China, Hefei, Anhui, People’s Republic of China
Search for other papers by Suowen Xu in
Google Scholar
PubMed
Search for other papers by Zhi Zhang in
Google Scholar
PubMed
Institute of Endocrine and Metabolic Diseases, University of Science and Technology of China, Hefei, Anhui, People’s Republic of China
Search for other papers by Wei Wang in
Google Scholar
PubMed
Introduction Type 2 diabetes (T2D), the most common form of diabetes, has fallen into the leading causes of disability and death worldwide. The harms of T2D arise from its complications such as neuropathy, nephropathy, retinopathy, and
INSERM U1018, Université Paris Sud, Centre for Research in Epidemiology and Population Health, Hôpital Paul Brousse, Bât 15/16, 16 Avenue Paul Vaillant Couturier, 94807 Paris, Villejuif Cedex, France
Search for other papers by Richard H Tuligenga in
Google Scholar
PubMed
Introduction Patients with type 2 diabetes mellitus show faster cognitive decline compared with healthy subjects (1) . Numerous studies in patients with type 2 diabetes have dealt with the association between the level of glycaemic control and the
Search for other papers by Emanuela Zaharieva in
Google Scholar
PubMed
Search for other papers by Zdravko Kamenov in
Google Scholar
PubMed
Search for other papers by Tsvetelina Velikova in
Google Scholar
PubMed
Search for other papers by Adelina Tsakova in
Google Scholar
PubMed
Search for other papers by Yosif El-Darawish in
Google Scholar
PubMed
Search for other papers by Haruki Okamura in
Google Scholar
PubMed
helper immune response ( 3 , 4 ). Apart from its place in immune defense against infective pathogens, IL-18 participates in the pathogenesis of atopic, autoimmune and chronic inflammatory diseases ( 3 , 4 ). Obesity and type 2 diabetes (T2D) have been
Search for other papers by Merlin C Thomas in
Google Scholar
PubMed
Search for other papers by Brendon L Neuen in
Google Scholar
PubMed
Department of Endocrinology, Royal Prince Alfred Hospital, Sydney, NSW, Australia
Search for other papers by Stephen M Twigg in
Google Scholar
PubMed
Search for other papers by Mark E Cooper in
Google Scholar
PubMed
Department of Renal Medicine, St George Hospital, Sydney, NSW, Australia
Faculty of Medicine and Health, University of New South Wales, Sydney, NSW, Australia
Search for other papers by Sunil V Badve in
Google Scholar
PubMed
Introduction At least half of all adults with type 2 diabetes (T2D) have comorbid chronic kidney disease (CKD), with either an elevated urinary albumin excretion rate (uAER) and/or a reduced estimated glomerular filtration rate (eGFR) ( 1 , 2
Search for other papers by Alessandra Gambineri in
Google Scholar
PubMed
Search for other papers by Carla Pelusi in
Google Scholar
PubMed
Role of sex and gender on the development of type 2 diabetes There is increasing evidence that sex and gender differences influence the epidemiology, pathophysiology, treatment and outcomes of many diseases, including type 2 diabetes (T2DM
Search for other papers by Cheryl M Isherwood in
Google Scholar
PubMed
Search for other papers by M Denise Robertson in
Google Scholar
PubMed
Search for other papers by Debra J Skene in
Google Scholar
PubMed
Search for other papers by Jonathan D Johnston in
Google Scholar
PubMed
obesity, type 2 diabetes mellitus (T2D) and circadian rhythmicity have been reviewed elsewhere ( 12 ). In one notable study, mice made obese by a high-fat diet exhibit reduced amplitude of circadian rhythms ( 17 ), although these effects may be due to diet